ANTI-GLYPICAN 3 ANTIBODY

An antibody capable of binding to a specific region of glypican 3, as well as a humanized antibody created based on that antibody are disclosed. The anti-GPC3 antibody of the invention has a higher ADCC activity and CDC activity compared with those of a conventional antibody. The antibody of the pre...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: TANAKA, MEGUMI, KINOSHITA, YASUKO, NEZU, JUN-ICHI, KONISHI, HIROKO, ISHIGURO, TAKAHIRO, SUGO, IZUMI, YOSHINO, TAKESHI, IGAWA, TOMOYUKI, KAWAI, SHIGETO, NAKANO, KIYOTAKA, TSUNODA, HIROYUKI
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:An antibody capable of binding to a specific region of glypican 3, as well as a humanized antibody created based on that antibody are disclosed. The anti-GPC3 antibody of the invention has a higher ADCC activity and CDC activity compared with those of a conventional antibody. The antibody of the present invention is useful as a cell growth inhibitor, an anticancer agent and an agent for diagnosis of cancers. Anticorps capable de se lier à une région spécifique du glypican 3 et anticorps humanisé élaboré à partir de l'anti-corps ci-dessus. L'anticorps anti-GPC3 décrit ci-dessus, qui a des activités ADCC et CDC élevées comparées aux anticorps existants, est utile en tant qu'inhibiteur de prolifération de cellule, en tant qu'agent anticancéreux, et dans le diagnostic du cancer.